Tag: Pfizer
The Emerging Paradigm in HIV Therapeutics Offers Hope for a Cure
Human Immunodeficiency Virus (HIV) compromises the body’s immunity by attacking CD4 cells (a type of T cell), exposing it to a host of infections...
Research in Biologics and Small Molecules aim to unravels the genetics...
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes the body’s immune system to attack healthy tissue causing inflammation, photosensitivity, oral ulcers, pleuritis,...
Cortexyme: Addressing Unmet Needs in the Alzheimer’s Market
The stocks of Cortexyme, Inc (NASDAQ: CRTX), a clinical stage biopharmaceutical company engaged in developing novel therapeutics for Alzheimer’ disease, surged by almost 70%...
Gene Therapy and Exon Skipping offer hope for patients with Duchenne...
The Muscular Dystrophy Association describes Duchenne Muscular Dystrophy (DMD) as a fatal, X-linked genetic neuromuscular disorder that leads to progressive, irreversible loss of muscle...
Emerging Paradigms in the Anticoagulant Industry
Anticoagulants have wide applications for prevention of blood clots in treatment of conditions such as pulmonary embolism, deep vein thrombosis (DVT), atrial fibrillation, stroke...
5 COMPANIES RESHAPING THE BRAIN METASTASES TREATMENT INDUSTRY
Metastatic brain tumor, also known as secondary cancer, is the most common brain tumor in adults and is estimated to affect between 200,000 and...
We are looking for talented interns to learn and help investors find valuable companies.